Wilson TO - Search Results

1

HER-2/neu expression: a major prognostic factor in endometrial cancer.

Hetzel DJ, Wilson TO, Keeney GL, Roche PC, Cha SS, Podratz KC. Hetzel DJ, et al. Among authors: wilson to. Gynecol Oncol. 1992 Nov;47(2):179-85. doi: 10.1016/0090-8258(92)90103-p. Gynecol Oncol. 1992. PMID: 1361478

2

Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.

Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, Podratz KC. Mariani A, et al. Among authors: wilson to. Gynecol Oncol. 2008 Apr;109(1):11-8. doi: 10.1016/j.ygyno.2008.01.023. Epub 2008 Mar 4. Gynecol Oncol. 2008. PMID: 18304622 Free PMC article.

3

The impact of surgical guidelines and periodic quality assessment on the staging of endometrial cancer.

Bakkum-Gamez JN, Mariani A, Dowdy SC, Weaver AL, McGree ME, Cliby WA, Gostout BS, Stanhope CR, Wilson TO, Podratz KC. Bakkum-Gamez JN, et al. Among authors: wilson to. Gynecol Oncol. 2011 Oct;123(1):58-64. doi: 10.1016/j.ygyno.2011.06.018. Epub 2011 Jul 13. Gynecol Oncol. 2011. PMID: 21741696

4

DNA ploidy in endometrial carcinoma: major objective prognostic factor.

Britton LC, Wilson TO, Gaffey TA, Cha SS, Wieand HS, Podratz KC. Britton LC, et al. Among authors: wilson to. Mayo Clin Proc. 1990 May;65(5):643-50. doi: 10.1016/s0025-6196(12)65126-x. Mayo Clin Proc. 1990. PMID: 2348728

5

Flow cytometric DNA analysis of stage I endometrial carcinoma.

Britton LC, Wilson TO, Gaffey TA, Lieber MM, Wieand HS, Podratz KC. Britton LC, et al. Among authors: wilson to. Gynecol Oncol. 1989 Sep;34(3):317-22. doi: 10.1016/0090-8258(89)90165-0. Gynecol Oncol. 1989. PMID: 2767522

6

Intraoperative radiation therapy in gynecologic cancer: the Mayo Clinic experience.

Garton GR, Gunderson LL, Webb MJ, Wilson TO, Martenson JA Jr, Cha SS, Podratz KC. Garton GR, et al. Among authors: wilson to. Gynecol Oncol. 1993 Mar;48(3):328-32. doi: 10.1006/gyno.1993.1057. Gynecol Oncol. 1993. PMID: 8385058

7

Deoxyribonucleic acid analysis facilitates the pretreatment identification of high-risk endometrial cancer patients.

Podratz KC, Wilson TO, Gaffey TA, Cha SS, Katzmann JA. Podratz KC, et al. Among authors: wilson to. Am J Obstet Gynecol. 1993 Apr;168(4):1206-13; discussion 1213-5. doi: 10.1016/0002-9378(93)90370-x. Am J Obstet Gynecol. 1993. PMID: 8475967

8

Prognostic value of p53 and proliferating cell nuclear antigen expression in endometrial carcinoma.

Hamel NW, Sebo TJ, Wilson TO, Keeney GL, Roche PC, Suman VJ, Hu TC, Podratz KC. Hamel NW, et al. Among authors: wilson to. Gynecol Oncol. 1996 Aug;62(2):192-8. doi: 10.1006/gyno.1996.0214. Gynecol Oncol. 1996. PMID: 8751548

9

Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?

Cliby WA, Aletti GD, Wilson TO, Podratz KC. Cliby WA, et al. Among authors: wilson to. Gynecol Oncol. 2006 Dec;103(3):797-801. doi: 10.1016/j.ygyno.2006.08.047. Epub 2006 Oct 18. Gynecol Oncol. 2006. PMID: 17052746

10

Pattern of retroperitoneal dissemination of primary peritoneum cancer: basis for rational use of lymphadenectomy.

Aletti GD, Powless C, Bakkum-Gamez J, Wilson TO, Podratz KC, Cliby WA. Aletti GD, et al. Among authors: wilson to. Gynecol Oncol. 2009 Jul;114(1):32-6. doi: 10.1016/j.ygyno.2009.03.020. Epub 2009 Apr 9. Gynecol Oncol. 2009. PMID: 19361840

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters